Morgan Stanley
SLSN

Morgan Stanley’s Solesence Inc SLSN Stock Holding History

Morgan Stanley’s Portfolio SLSN Stock Details SLSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Buy
194,782
+159,494
+452% +$202K ﹤0.01% 5908
2025
Q4 		$56.3K Buy
35,288
+19,497
+123% +$52.8K ﹤0.01% 6396
2025
Q3 		$50.8K Sell
15,791
-17,033
-52% -$61K ﹤0.01% 6390
2025
Q2 		$143K Buy
+32,824
New +$115K ﹤0.01% 5987

Other funds holding SLSN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Morgan Stanley's SLSN Position: Q1 2026 in Review

Morgan Stanley increased its Solesence Inc (SLSN) stake by 452% in Q1 2026, buying an estimated $202K and bringing the position to 194,782 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #5908.

Morgan Stanley first reported a position in SLSN in Q2 2025 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold SLSN as of Q1 2026.

  • Morgan Stanley held 194,782 shares of Solesence Inc worth $185K as of Q1 2026.
  • Morgan Stanley bought 159,494 Solesence Inc shares in Q1 2026, an estimated $202K.
  • Solesence Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5908 holding.
  • Morgan Stanley first reported a position in Solesence Inc in Q2 2025 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held Solesence Inc as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.